Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2697 |
|
Actual shortage: | 238 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2450 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
23 (10%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
ACT PRAMIPEXOLE | 0.5MG | TABLET | Resolved | 2021-06-10 | 2021-09-02 | 140660 |
ACT PRAMIPEXOLE | 0.25MG | TABLET | Resolved | 2021-07-08 | 2021-09-02 | 142172 |
ACT PRAMIPEXOLE | 0.25MG | TABLET | Avoided shortage | 2021-07-15 | 2021-07-15 | 142575 |
ACT PRAMIPEXOLE | 0.5MG | TABLET | Resolved | 2021-11-18 | 2021-12-23 | 149588 |
ACT PRAMIPEXOLE | 0.25MG | TABLET | Resolved | 2023-04-27 | 2024-01-11 | 190719 |
ACT PRAMIPEXOLE | 1MG | TABLET | Resolved | 2023-04-27 | 2024-01-11 | 190722 |
ACT PRAMIPEXOLE | 1.5MG | TABLET | Resolved | 2023-04-27 | 2024-01-11 | 190725 |
ACT PRAMIPEXOLE | 1MG | TABLET | Resolved | 2023-06-16 | 2023-07-05 | 195127 |
ACT PRAMIPEXOLE | 1.5MG | TABLET | Resolved | 2023-06-19 | 2023-07-05 | 195466 |
ACT PRAMIPEXOLE | 0.25MG | TABLET | Resolved | 2023-06-19 | 2023-07-05 | 195582 |
ACT PRAMIPEXOLE | 0.5MG | TABLET | Resolved | 2023-10-26 | 2024-01-11 | 208260 |
ACT PROGESTERONE INJECTION | 50MG | SOLUTION | Resolved | 2019-10-24 | 2020-05-14 | 97147 |
ACT PROGESTERONE INJECTION | 50MG | SOLUTION | Actual shortage | 2021-11-18 | 2022-08-18 | 149602 |
ACT QUETIAPINE | 25MG | TABLET | Resolved | 2019-09-05 | 2020-09-18 | 93166 |
ACT QUETIAPINE | 25MG | TABLET | Resolved | 2019-09-19 | 2020-07-10 | 94384 |
ACT QUETIAPINE | 25MG | TABLET | Resolved | 2019-10-10 | 2020-03-05 | 96079 |
ACT QUETIAPINE | 100MG | TABLET | Resolved | 2020-04-10 | 2020-10-22 | 111838 |
ACT QUETIAPINE | 25MG | TABLET | Resolved | 2020-08-06 | 2021-01-07 | 121852 |
ACT QUETIAPINE | 200MG | TABLET | Resolved | 2020-08-27 | 2020-09-17 | 123078 |
ACT QUETIAPINE | 100MG | TABLET | Resolved | 2020-09-24 | 2020-10-01 | 124918 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
ACT CELECOXIB | 100MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123648 |
ACT CELECOXIB | 200MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123651 |
ACT CELECOXIB | 200MG | CAPSULE | Discontinued | 2021-02-12 | 2021-02-12 | 133874 |
ACT CELECOXIB | 100MG | CAPSULE | Discontinued | 2021-02-12 | 2021-02-12 | 133880 |
ACT CLOPIDOGREL | Discontinued | 2018-10-19 | 2018-10-19 | 65065 | ||
ACT DILTIAZEM CD | 120MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2019-04-11 | 2019-04-11 | 81381 |
ACT DILTIAZEM CD | 180MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2019-04-11 | 2019-04-11 | 81418 |
ACT DILTIAZEM CD | 120MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2021-07-22 | 2021-07-22 | 142915 |
ACT DILTIAZEM CD | 300MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2021-07-22 | 2021-07-22 | 142918 |
ACT DILTIAZEM CD | 180MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2021-07-22 | 2021-07-22 | 142921 |
ACT DILTIAZEM T | 360MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-05-14 | 2020-05-14 | 115114 |
ACT DILTIAZEM T | 120MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-05-14 | 2020-05-14 | 115117 |
ACT DILTIAZEM T | 180MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-05-14 | 2020-05-14 | 115120 |
ACT DILTIAZEM T | 240MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-05-14 | 2020-05-14 | 115123 |
ACT DILTIAZEM T | 300MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-05-14 | 2020-05-14 | 115126 |
ACT DONEPEZIL ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64872 |
ACT DONEPEZIL ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64875 |
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 |